Since TGF-β1 signaling is a major driver of UUO-induced renal fibrosis (Richards et al., 2018), clarification of the involved intermediates downstream of the activated TGF-β receptors may have therapeutic implications for patients with UPJ disease. The gene discussed is TGFB1; the disease is renal fibrosis.